SWP
OGEN icon

Strategic Wealth Partners’s Oragenics OGEN Stock Holding History

Strategic Wealth Partners’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 1458
2026
Q1 		$1 Hold
1
– – ﹤0.01% 1473
2025
Q4 		$1 Hold
1
– – ﹤0.01% 1455
2025
Q3 		$1 Hold
1
– – ﹤0.01% 1314
2025
Q2 		$4 Buy
+1
New +$5 ﹤0.01% 1145

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
2L
25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Strategic Wealth Partners's OGEN Position: Q2 2026 in Review

Strategic Wealth Partners held its Oragenics (OGEN) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1458.

Strategic Wealth Partners first reported a position in OGEN in Q2 2025 and has held it in 5 quarters since. The position peaked at $4 in Q2 2025. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

  • Strategic Wealth Partners held 1 share of Oragenics worth $1 as of Q2 2026.
  • Strategic Wealth Partners left its Oragenics share count unchanged in Q2 2026.
  • Oragenics made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q2 2026, its #1458 holding.
  • Strategic Wealth Partners first reported a position in Oragenics in Q2 2025 and has held it in 5 quarters since.
  • Strategic Wealth Partners's Oragenics position peaked at $4 in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.